[PLX] QoQ Quarter Result on 31-Mar-2010 [#Q1]

Stock
[PLX] Protalix BioTherapeutics, Inc.
Announcement Date
10-May-2010
Financial Year
2010
Quarter
31-Mar-2010 [#Q1]
Profit Trend
QoQ- 46.74%
YoY- -53.48%
Quarter Report
PLX's Result
PLX's Financial Summary
View:
Show?
Quarter Result
31/12/10 30/09/10 30/06/10 31/03/10 31/12/09 30/09/09 30/06/09 CAGR
Revenue 1,176 3,184 1,141 1,141 388 0 0 -
PBT 22,414 0 0 -7,955 31,440 0 0 -
Tax -20,470 -374 -109 0 -16,504 -152 -446 1172.99%
NP -8,528 -2,474 -10,041 -7,955 -14,936 -5,894 -5,427 35.05%
Tax Rate 91.33% - - - 52.49% - - -
Total Cost 9,704 5,658 11,182 9,096 15,324 5,894 5,427 47.16%
Ratio Analysis
31/12/10 30/09/10 30/06/10 31/03/10 31/12/09 30/09/09 30/06/09 CAGR
NP Margin -725.17 -77.70 -880.02 -697.20 -3,849.48 0.00 0.00 -
Per Share
31/12/10 30/09/10 30/06/10 31/03/10 31/12/09 30/09/09 30/06/09 CAGR
EPS -1.04 -0.03 -0.12 -0.10 -1.85 -0.08 -0.07 501.38%
EPS Diluted -1.04 -0.03 -0.12 -0.10 -1.85 -0.08 -0.07 501.38%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.